13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001912294
Total reported value
$1.3M
$1.3M
1 檔
157.7%
In Q4 2024, Sozo Ventures GP II, L.P.'s U.S. equity holdings reached a combined market value of $1.3M, distributed across 1 disclosed stock positions.
Sozo Ventures GP II, L.P. executed strategic sector rebalancing during Q4 2024, establishing 1 new positions while fully exiting 1 holdings and trimming 0 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MGX | Metagenomi Therapeutics Inc | Stock-Other | 100.00% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MGX | Metagenomi Therapeutics Inc | +100% | NEW | New buy |
| 2 | COIN | Coinbase Global Inc -class A | -100% | EXIT | Sold out |
According to official SEC Form 13F filings, Sozo Ventures GP II, L.P. reported a total U.S. public equity portfolio value of $1.3M across 1 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including MGX) accounted for 157.7% of total reported equity market value during Q4 2024.
Top New Position Initiated
MGX
市值: $2.1M
Top Position Liquidated / Trimmed
COIN
前期市值: $193.3M
During Q4 2024, Sozo Ventures GP II, L.P.'s top holdings by market value included MGX (100.0%). The largest single position, MGX, represented 100.0% of total portfolio value.
In Q4 2024, Sozo Ventures GP II, L.P. made 2 total portfolio adjustments, initiating 1 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.